EMA and EC Release Joint Paper on Biosimilars

The European Medicines Agency (EMA) and the European Commission (EC) have presented a joint paper titled ‘Biosimilars in the EU. Information Guide for Healthcare Professionals’, during the Third Stakeholder Conference on Biosimilar Medicines.

The paper concludes that after 10 years of clinical experience with biosimilars, it can be stated that “they can be used with the same guarantee of safety and efficacy in all the approved indications that their biological Reference”, since there are only “minor differences that are not clinically significant”.

Read the full story here.

Tagged with

Published on 8. May 2017 in News EU